Parkinson's patients may sharpen driving skills with simulator training
NCT ID NCT07463755
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether 10 sessions of low-fidelity driving simulator training can improve driving performance, confidence, and thinking skills in people with Parkinson's disease. 36 participants will be randomly assigned to either the simulator training or a waitlist group. Researchers will compare driving tests and cognitive scores before and after the training period.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- low-fidelity driving simulator training
- What this could lead to
- If it works, this could point toward a non-drug therapy to help people with Parkinson's drive more safely and confidently.
- What could go wrong
- This is a very small pilot study (36 people) with no blinding. The training is on a basic simulator, so improvements may not carry over to real driving. Results are preliminary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mobility and Falls Lab
Kansas City, Kansas, 66103, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a mediterranean diet and exercise ease Parkinson's by reshaping the gut?
- CBD oil shows promise for easing anxiety and depression in Parkinson's patients
- Could a Brain-Healthy diet help fight ALS and Parkinson's?
- Parkinson's treatment could go monthly: new injection tested
- Smartphone beats could steady Parkinson's steps
- Parkinson's patients get new hope: group therapy targets anxiety and depression